The RETINAL project begins its digital expansion

2018/12/03

The RETINAL project, an activity of ULMA Medical Imaging that was initiated in 2012, uses the digital world to advertise its products and services.

After receiving a European subsidy last year in the amount of €1.45M, the project has strengthened its activity and it is now the ideal time to present it to the world using different digital tools.

The current proposal by RETINAL consists of devising a comprehensive solution capable of diagnosing diabetic retinopathy in a matter of second.

Social networks and a new website with an attractive, clean design that can be opened with any device are some of the tools that ULMA Medical Imaging has identified as key for advertising in the different health market channels. This website also includes a video that provides a visual explanation of the current diabetic retinopathy* problem and how ULMA proposes an easy, quick and safe solution based on artificial intelligence for early detection of this disease.

*Diabetic retinopathy is the main cause of loss of vision and blindness in people with diabetes.

Join and help us to disseminate our project!

An alliance between ULMA Medical Imaging and MiiS to develop medical imaging equipment

2018/12/07

In October, ULMA Medical Imaging entered into a collaboration and distribution agreement with Medimaging Integrated Solutions Inc. (MiiS), for co-developing and manufacturing medical image capturing equipment under the ULMA brand.

MiiS is a Taiwanese company and world leader in manufacturing portable equipment for capturing retinal imaging. Since its inception it has specialised in designing and manufacturing portable optic devices used for obtaining high quality medical images with interchangeable objects for different medical specialities such as ophthalmology and dermatology, among others.

This alliance will at first allow production of an ULMA brand high performance retinal camera, and in the future, the co-development of other medical imagery devices for the new line of work of ULMA Medical Imaging.

Apart from the agreement reached in the technological area, the alliance includes a commercial agreement to distribute their product catalogue worldwide.

Close New

Agreement between ULMA-ICQO for the development of the "RETINAL Project"

2018/07/03

Last April ULMA signed a collaboration agreement with the Clinical Surgical Institute of Ophthalmology (ICQO) for the joint development of different diagnostic tools in the area of the retina.

Throughout 2018 a team of 6 people from ICQO will collaborate in the development of ULMA’s RETINAL project. The ophthalmologist Iñigo Corcostegui and his team will work hand in hand with ULMA staff in the different project phases to obtain a comprehensive ophthalmological solution that responds to the current needs of the health sector.

The ICQO, created in Bilbao in 1995 by ophthalmologists Gonzalo Corcóstegui and Juan Durán de la Colina, is an ophthalmological teaching centre, linked to the University of the Basque Country. It works in eight ophthalmological specialties (refraction, retina-vitreous, cornea and ocular surface alterations, glaucoma, low vision, etc.) and has an R & D unit with several research lines, from which several patents have emerged, such as a cornea cutting instrument and an intraocular injections system.

Close New